Parth Modi to Carcinoma, Renal Cell
This is a "connection" page, showing publications Parth Modi has written about Carcinoma, Renal Cell.
Connection Strength
0.713
-
Impact of pathologic lymph node-positive renal cell carcinoma on survival in patients without metastasis: Evidence in support of expanding the definition of stage IV kidney cancer. Cancer. 2020 07 01; 126(13):2991-3001.
Score: 0.135
-
Factors Associated With Receipt of Partial Nephrectomy or Minimally Invasive Surgery for Patients With Clinical T1a and T1b Renal Masses: Implications for Regionalization of Care. Clin Genitourin Cancer. 2020 12; 18(6):e643-e650.
Score: 0.135
-
Accuracy of clinical nodal staging and factors associated with receipt of lymph node dissection at the time of surgery for nonmetastatic renal cell carcinoma. Urol Oncol. 2019 09; 37(9):577.e17-577.e25.
Score: 0.128
-
Trends and outcomes of lymphadenectomy for nonmetastatic renal cell carcinoma: A propensity score-weighted analysis of the National Cancer Database. Urol Oncol. 2019 01; 37(1):26-32.
Score: 0.123
-
Contemporary trends in high-dose interleukin-2 use for metastatic renal cell carcinoma in the United States. Urol Oncol. 2015 Nov; 33(11):496.e11-6.
Score: 0.097
-
Increased Expression of Androgen Receptor mRNA in Human Renal Cell Carcinoma Cells is Associated with Poor Prognosis in Patients with Localized Renal Cell Carcinoma. J Urol. 2015 Nov; 194(5):1441-8.
Score: 0.095